The pharmaceutical industry is developing new vaccines
to prevent or mitigate the effects of diseases across
the globe, which will substantially boost market demand.
The worldwide vaccine market is expected to reach more
than $10 billion in 2007, according to “Vaccines:
The World Market,” a report from the medical market
research firm Kalorama Information.
The report states that vaccines are being tested in
several areas including for HIV, several forms of cancer,
and other diseases including Epstein-Barr virus, Hepatitis
C, and herpes.
The report also predicts that as many as five new vaccines
to treat cancer may soon be available, creating an $8
billion dollar cancer vaccine market by 2012, representing
over half of the $15 billion total vaccine market that
will exist that year, according to Kalorama.
Kalorama Information publisher Steven Heffner states
that along with developing vaccines, other issues in
developing nations must be addressed to increase survival
rates including routine exams, drug safety issues, the
availability of drug supplies, the reuse of needles and
needle-stick injuries.
“There are certainly major issues hindering the
wider usage of current vaccines on a global level,” Heffner
said. “However, most are being seriously addressed
by the world health community, and investments in advanced
therapeutics technologies as well as novel approaches
to vaccine delivery abound.”
RSI - Executive Search Firm News | Executive & Candidate
Resources for the Executive Search Recruiting Industry
Current Location: Executive Search Firm Industry Articles - Vaccine Market Booming
Search Solutions
RSI's Executive Search
Process will find the best Candidate for your position.
RSI's Executive Recruiting
Experts bring Employers only the best Executive talent.